HistoGeneX, headquartered in Belgium, is a leading provider in the field of precision medicine and pathology services. Founded in 2005, the company has established itself as a key player in the biopharmaceutical industry, specialising in advanced histopathology and biomarker analysis. With operational regions spanning Europe and North America, HistoGeneX offers a comprehensive range of services, including tissue diagnostics and digital pathology solutions. The company is renowned for its innovative approach to histology, utilising cutting-edge technology to deliver high-quality, reproducible results. HistoGeneX's commitment to excellence has positioned it as a trusted partner for pharmaceutical companies and research institutions, contributing to significant advancements in personalised medicine. With a strong focus on quality and customer satisfaction, HistoGeneX continues to achieve notable milestones in the evolving landscape of healthcare.
How does HistoGeneX's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
HistoGeneX's score of 6 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HistoGeneX, headquartered in Belgium (BE), currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. While there are no documented reduction targets or climate pledges available, it is essential to note that many companies in the life sciences sector are increasingly focusing on sustainability and carbon neutrality. HistoGeneX may be engaging in similar initiatives to align with industry standards and contribute to global climate goals. For a comprehensive understanding of HistoGeneX's climate commitments and emissions profile, further information would be required.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HistoGeneX is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.